tocophersolan has been researched along with Sarcoma 180 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, Y; Si, L; Song, Q; Tan, S; Wu, T; Ye, Q; Zhang, Z; Zhao, Y; Zhuang, X | 1 |
1 other study(ies) available for tocophersolan and Sarcoma 180
Article | Year |
---|---|
Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Doxorubicin; Drug Carriers; Female; Half-Life; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Micelles; Nitric Oxide; Polyethylene Glycols; Rats, Sprague-Dawley; Sarcoma 180; Tissue Distribution; Vitamin E | 2014 |